Zebra Technologies to Release First-Quarter Results on May 9

LINCOLNSHIRE, Ill.--(BUSINESS WIRE)-- Zebra Technologies Corporation (NASDAQ: ZBRA), a global leader in providing solutions and services that give enterprises real-time visibility into their operations, will report its first-quarter 2017 financial results on Tuesday, May 9, 2017.

The company will also host a conference call to discuss these results on the same day at 7:30 a.m. CT (8:30 a.m. ET). To listen to the live webcast of the presentation, visit the Investor Relations section of the company’s website at investors.zebra.com. The webcast will be archived and available on the website for at least one year following the call.

About Zebra

With the unparalleled visibility Zebra (NASDAQ: ZBRA) provides, enterprises become as smart and connected as the world we live in. Real-time information – gleaned from visionary solutions including hardware, software and services – gives organizations the competitive edge they need to simplify operations, know more about their businesses and customers, and empower their mobile workers to succeed in today’s data-centric world. For more information, visit www.zebra.com or sign up for our news alerts. Follow us on LinkedIn, Twitter and Facebook.

©2017 ZIH Corp. All rights reserved. Zebra and the stylized Zebra head are trademarks of ZIH Corp., registered in many jurisdictions worldwide. All other trademarks are the property of their respective owners.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170502006063/en/

Zebra Technologies Corporation
Investors:
Michael Steele, CFA, IRC
Vice President, Investor Relations
Phone: + 1 847 793 6707
[email protected]
or
Media:
Therese Van Ryne
Director, Global Public Relations
Phone: + 1 847 370 2317
[email protected]

Source: Zebra Technologies Corporation

You May Also Be Interested In

• Wolfe Research starts Ferrari at Outperform, sees 'solid upside potential'
• bioAffinity Technologies Q2 CyPath Lung sales rise over 200% year-over-year
• Praxis strikes deal with Remagine Labs on transdermal ET drug patch